NATHAN MARKS: Open Payments
NPI 1144090283 · LEBANON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 34 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,785 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $316 |
| Novo Nordisk Inc | 4 | $90 |
| Lilly USA, LLC | 3 | $51 |
| ABBVIE INC. | 2 | $43 |
| Corcept Therapeutics | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Amgen Inc. | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
Products named: AIRSUPRA, BREZTRI, Ozempic, QULIPTA, Korlym, SHINGRIX, MOUNJARO, INSPIRE.
Industry payments across TN — which companies pay providers there.
